Get startedLog in
    Picture of Vicore Pharma Holding AB logo

    VICO — Vicore Pharma Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Vicore Announces FDA Acceptance For Pivotal Phase 3 Trial Of C21 In COVID-19

    Picture of Vicore Pharma Holding AB logoVicore Pharma Holding AB
    11/06/2021 07:05
    June 11 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * VICORE ANNOUNCES FDA ACCEPTANCE FOR PIVOTAL PHASE 3 TRIAL OF C21 IN COVID-19
    * VICORE ANNOUNCES FDA ACCEPTANCE FOR PIVOTAL PHASE 3 TRIAL OF C21 IN COVID-19

Source text for Eikon:  ID:nWkrsjkdk 
Further company coverage:  VICOR.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on Vicore Pharma Holding AB

    See all news